博文

Summary of Hualan Bio’s IVIG, Human Immunoglobulin (pH4) for Intravenous Injection

图片
Summary of Hualan Bio’s IVIG, Human Immunoglobulin (pH4) for Intravenous Injection HumanImmunoglobulin (pH4) for Intravenous Injection, IVIG is a liquid preparation made from healthy human plasma, separated and purified by low temperature ethyl alcohol protein separation, and inactivated by double virus inactivation including at least 10 hours of Pap inactivated in 60 ± 0.5 ℃ and at least 21 days of low ph incubation at 23 ~ 25 ℃ . The active ingredient is humanimmunoglobulin , and contains appropriate amount of maltose, polysorbate 80 as a stabilizer, without preservatives and antibiotics. Clinically, it is mainly used to treat various primary and secondary immunoglobulin deficiency diseases and some autoimmune diseases.  HualanBio’s IVIG, Human Immunoglobulin (pH4) forIntravenous Injection

What You Should Know About Flu Antiviral Drugs?

图片
What You Should Know About Flu Antiviral Drugs? 1. Can the flu be treated? Yes. There are prescription medications called “antiviral drugs” that can be used to treat flu illness. 2. What should I do if I think I have the flu? If you get the flu, antiviral drugs are a treatment option. Check with your doctor promptly if you are at high risk of serious flu complications (see box below for the full list of high risk factors) and you develop flu symptoms. Flu signsand symptoms can include feeling feverish or having a fever, cough, sore throat, runny or stuffy nose, body aches, headache, chills and fatigue. Your doctor may prescribe antiviral drugs to treat your flu illness. 3. Should I still get a flu vaccine? Yes. Antiviral drugs are not a substitute for getting a flu vaccine . While flu vaccine can vary in how well it works, a flu vaccine is best way to help prevent seasonal flu and its potentially serious complications. Antiviral drugs are a second li...

Take everyday preventive actions to stop the spread of germs of influenza.

图片
Take everyday preventive actions to stop the spreadof germs of influenza. -Try to avoid close contact with sick people. -While sick, limit contact with others as much as possible to keep from infecting them. -If you are sick with flu-like illness , CDC recommends that you stay home for at least 24 hours after your fever is gone except to get medical care or for other necessities. (Your fever should be gone for 24 hours without the use of a fever-reducing medicine.) -Cover your nose and mouth with a tissue when you cough or sneeze. After using a tissue, throw it in the trash and wash your hands. -Wash your hands often with soap and water. If soap and water are not available, use an alcohol-based hand rub. -Avoid touching your eyes, nose and mouth. Germs spread this way. -Clean and disinfect surfaces and objects that may be contaminated with germs like flu. Takeeveryday preventive actions to stop the spread of germs of influenza . ...

About 7 Million People Infected Flu in the U.S. in 2018-2019 Flu Season

图片
About 7 Million People Infected Flu in the U.S. in 2018-2019 Flu Season Flu has sickened 6.15 to 7.28 million people in the United States from October 01, 2018 through January 5, 2019, about half to the medical visits, 69.3 to 83.5 thousand to hospitalizations, according to estimates released by CDC. The best way to prevent seasonal flu is to get vaccinated every year. CDC recommends a yearly flu vaccine as the first and most important step in protecting against influenza and its potentially serious complications. Prevent Flu by Vaccine While there are many different flu viruses, flu vaccines protect against the 3 or 4 viruses that research suggests will be most common. Three-component vaccines contain an H3N2, an H1N1 and a B virus. Four component vaccines have an additional B virus component. Flu vaccination can reduce flu illnesses, doctors’ visits, and missed work and school due to flu, as well as prevent flu-related hospitalizations. Flu vaccination also has been sho...

Development and Industrialization Construction Project of Quadrivalent Influenza Vaccine of Hualan Biological Bacterin Co., Ltd

图片
Development and Industrialization Construction Project of Quadrivalent Influenza Vaccine of Hualan Biological Bacterin Co., Ltd HualanBiological Bacterin Co., Ltd is a high and new tech enterprises specializing in vaccines, situated at Jia No.1-1, Hualan Ave., High-tech Zone, Xinxiang, Henan, China. In order to improve the overall strength of the enterprise, Hualan Bio plans to build a project for the development and industrialization of InfluenzaVaccine (Split, Virion), Inactivated, Quadrivalent . The production scale is 15 million doses of Quadrivalent Influenza Vaccine per year. The construction content is to transform the production workshop, install production equipment and supporting facilities, adopt influenza virus strains recommended by the World Health Organization and approved by the drug administration department under the State Council, and develop a new type of highly effective influenza vaccine by optimizing the preparation process of virus culture, harvesting,...

Hualan Genetic Recombinant Anti-CTLA-4 Human Monoclonal Antibody Injection (Ipilimumab) Starting Clinical Trial

图片
Hualan Genetic Recombinant Anti-CTLA-4 Human Monoclonal Antibody Injection (Ipilimumab) Starting Clinical Trial On October 10, 2018, Hualan GeneticEngineering Co., Ltd . received the clinical approval document of "Recombinant Anti-CTLA-4 Human Monoclonal Antibody Injection" issued by the State Drug Administration, with the approval number of 2018L03080. According to the drug registration procedure, Hualan Genetic Engineering Co., Ltd will organize and implement clinical trials as soon as possible in accordance with the requirements of the national drug clinical trials after obtaining the approval documents for the above drug clinical trials, and will apply the product production approval documents and GMP certificate after completing the clinical trials. With the registered capital of RMB 100 million Yuan, Hualan Genetic Engineering Co., Ltd. was established in June 2013. In May 2014, the company obtained Pharmaceutical Production License and devoted to the R...

Group AC Meningococcal Polysaccharide Vaccine of Hualan Biological Bacterin Co., Ltd Passing GMP

图片
Group AC Meningococcal Polysaccharide Vaccine of Hualan Bio logical Bacterin Co., Ltd Passing GMP On March 26, 2018, Hualan Biological Bacterin Co., Ltd received production licenses of Group AC Meningococcal Polysaccharide Vaccine issued by CFDA. On May 8, 2018, Hualan Biological Bacterin Co., Ltd got GMP Certificate issued by CFDA, the certificate number is HA20180019, the certification scope is Group AC Meningococcal Polysaccharide Vaccine, valid until April 27, 2023. Then the company is approved to produce and sell the vaccines offically.                                           http://english.hualanbio.com/information/shownews.php?lang=en& id=141